0001133416-23-000032.txt : 20230130
0001133416-23-000032.hdr.sgml : 20230130
20230130165528
ACCESSION NUMBER: 0001133416-23-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230126
FILED AS OF DATE: 20230130
DATE AS OF CHANGE: 20230130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zordani Richard A. Jr.
CENTRAL INDEX KEY: 0001827180
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31791
FILM NUMBER: 23568624
MAIL ADDRESS:
STREET 1: 467 N. COUNTRY RIDGE CT.
CITY: LAKE ZURICH
STATE: IL
ZIP: 60047
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC
CENTRAL INDEX KEY: 0001133416
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043562325
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
BUSINESS PHONE: 678-620-3186
MAIL ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
FORMER COMPANY:
FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010612
4
1
form4.xml
X0306
4
2023-01-26
0001133416
GALECTIN THERAPEUTICS INC
GALT
0001827180
Zordani Richard A. Jr.
C/O GALECTIN THERAPEUTICS INC.
4960 PEACHTREE INDUSTRIAL BLVD., STE 240
NORCROSS
GA
30071
true
Stock Option (right to buy)
1.11
2023-01-26
4
A
0
40000
0
A
2033-01-26
Common Stock
40000
40000
D
The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.
The options vest 100% on December 31, 2023.
Jack W. Callicutt, by power of attorney
2023-01-30